Haemonetics (HAE) said Monday it has appointed Frank Chan as executive vice president, chief operating officer, from April 7.
Chan most recently was the president of acute care and monitoring at Medtronic (MDT), the firm said.
The medical technology company said it also appointed Roy Galvin as executive vice president, chief commercial officer, effective immediately. Galvin joined Haemonetics in 2022 as president of global plasma and blood center.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.